Ptosis News and Research

RSS

New data illustrates evolving trends in breast enhancement over the past 16 years

Ongoing quality improvement data submitted by Board-certified plastic surgeons highlight current trends in surgical technique in cosmetic breast augmentation using implants, reports a study in the December issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

7 Dec 2023

Review examines visual disturbances among Parkinson’s disease patients

In a recent review published in Brain Sciences, researchers reviewed existing data on visual impairments among Parkinson’s disease (PD) patients.

9 Aug 2023

Dangerous weight loss trend triggers Iatrogenic botulism outbreak in Europe

Researchers study documents relevant laboratory and epidemiological data on travel-associated iatrogenic botulism outbreaks in Europe.

11 Jun 2023

Researchers develop a new smartphone-based tool to detect visual impairment in young children

Researchers conducted a prospective, multicenter, observational study between 14 January 2020 and 30 January 2022 in China.

30 Jan 2023

Women who have cluster headache are more affected in their daily lives, shows study

Cluster headache, sometimes known as "suicide headache", have been described as a predominantly male disease.

21 Dec 2022

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Study provides new insight into cluster headache chronicity

A prospective study recently published in the journal Cephalalgia, the official journal of the International Headache Society, extends the idea behind cluster headache chronicity.

2 Jan 2020

Study shows economic benefit of reconstructive surgery trips to developing countries

Trips to perform reconstructive surgery procedures in low- and middle-income countries (LMICs) are cost-effective in terms of reducing the impact of disability on the lives of patients, reports a special topic paper in the September issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

30 Aug 2019

Selenium protects specialized neurons from cell death during postnatal development

Exactly 200 years ago, the Swedish scientist Jöns Jacob Berzelius discovered the trace element selenium, which he named after the goddess of the moon, Selene.

29 Dec 2017

Two-stage approach improves outcomes for women with large breasts undergoing risk-reducing mastectomy

For women undergoing risk-reducing mastectomy to prevent breast cancer, reconstruction can be challenging in those with larger breasts.

30 Aug 2017

Five things that parents should know about pediatric eye surgery requiring anesthesia

Healthy eyes play an important role in a child's development, and sometimes more than just a new pair of glasses may be required.

1 Aug 2017

Three projects that focus on improving global health win DEBUT Challenge

Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.

24 Aug 2015

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

Allergan, plc. today announced that the company has received approval from the U.S. Food and Drug Administration to market 28 additional styles of Natrelle 410 silicone-filled breast implants, giving surgeons and patients more options to achieve desired outcomes.

6 Aug 2015

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

10 Mar 2015

Four new styles of MENTOR MemoryShape Breast Implants get FDA approval

Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration has approved four additional styles of the MENTOR MemoryShape Breast Implants, expanding its suite of silicone breast implant products.

15 Sep 2014

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Ipsen today announced positive initial results from the double-blind phase III study of Dysport (abobotulinumtoxinA) in Adult Upper Limb spasticity. Regarding the primary endpoints, treatment with Dysport showed statistically significant response versus placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale.

17 Dec 2013

FDA approves MENTOR MemoryShape Breast Implants

Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration has approved MENTOR MemoryShape Breast Implants, providing new options for women looking for a more natural shape and youthful feel from breast enhancement or reconstruction surgery.

15 Jun 2013

Prostaglandin analogues cause droopy eyelids, new study finds

Prostaglandin analogues, drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks.

22 May 2013

UBE3B gene linked to brain development disorder in children

Researchers have defined the gene responsible for a rare developmental disorder in children. The team showed that rare variation in a gene involved in brain development causes the disorder. This is the first time that this gene, UBE3B, has been linked to a disease.

30 Nov 2012

LEO Pharma receives FDA approval for Picato topical gel to treat AK

LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) approved Picato (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis.

27 Jan 2012